With potential as BD activity indicator, CXCR2 expressions on both total leukocytes and neutrophils in the relapsing phase has been shown to be significantly elevated in patients with ocular BD; low-dose prednisolone therapy reduces this expression on neutrophils (45). The gene discussed is CXCR2; the disease is Behcet disease.